Zhang Zhenxin

[Expert Profile] Zhang Zhenxin, Chief Physician, Professor, Doctoral Supervisor, is a senior authoritative expert in geriatric neurology and cognitive disorders in China, working at Peking Union Medical College Hospital. She has long been dedicated to the clinical diagnosis, treatment, and epidemiological research of Alzheimer's disease, Parkinson's disease, and various cognitive disorders, and is one of the important pioneers in dementia prevention and control research in China.

[Education & Career] Professor Zhang Zhenxin graduated from Peking Union Medical College, completed systematic resident and specialist training in the Department of Neurology at Peking Union Medical College Hospital, and further studied at renowned international medical institutions, systematically mastering cutting-edge international methods in neurodegenerative disease diagnosis and research. After returning to China, she has focused on geriatric neurology for decades, successively presiding over major research projects such as national science and technology key projects and the National Natural Science Foundation of China, and holding important positions in the Chinese Medical Association and Chinese geriatric medicine societies. She is a representative figure in epidemiological and clinical research on senile dementia in China.

[Areas of Expertise] Professor Zhang specializes in early identification and differential diagnosis of Alzheimer's disease and other types of dementia, Parkinson's disease and Parkinsonism, mild cognitive impairment (MCI), various cognitive dysfunctions, and the diagnosis and treatment of difficult neurological diseases in the elderly. She has extensive experience in the application of early dementia screening scales, interpretation of biomarkers, and standardized assessment, emphasizing "early detection, early diagnosis, and early intervention" to help numerous elderly patients and their families obtain scientific diagnosis and whole-course care guidance at early disease stages.

[Academic Achievements & Industry Contributions] Professor Zhang has led multiple large-scale community dementia epidemiological surveys, systematically mapping out the prevalence, risk factors, and disease burden of dementia and cognitive disorders among the elderly population in China, providing important evidence-based data for the formulation of dementia prevention and control policies. She has participated in the compilation of multiple national dementia prevention guidelines and expert consensus statements, actively promoted the standardized construction of memory clinics and cognitive disorder diagnosis centers, and provided systematic training for grassroots physicians, thereby promoting the nationwide adoption of standardized cognitive assessment and management methods and significantly improving the overall level of dementia prevention and control in China.

[Clinical Practice & Outstanding Contributions] For decades, Professor Zhang has remained on the front lines of clinical care, cumulatively treating tens of thousands of elderly patients with cognitive and movement disorders, bringing clarity and clear diagnoses to countless "forgetful elderly" and "trembling elderly" patients. She is exceptionally patient and meticulous with elderly patients, skilled at capturing early disease signals from family members' descriptions, and her consultation rooms are often filled with patients who have traveled from all over the country. Her students are distributed in neurology and geriatrics departments nationwide, becoming the backbone of dementia prevention efforts in their regions. She has herself been repeatedly recognized as an outstanding physician and advanced science and technology worker.

[Honors & Reputation] Professor Zhang Zhenxin has long served as leader of the Dementia and Cognitive Disorders Group of the Neurology Branch of the Chinese Medical Association, and has presided over multiple national-level projects including the national "Ninth Five-Year" and "Tenth Five-Year" science and technology key programs. She is one of the earliest experts in China to systematically conduct epidemiological and clinical research on dementia. She led China's first large-scale dementia prevalence survey, mapping out the current state of Alzheimer's disease and cognitive disorders in China, providing critical data for national and local policies on geriatric cognitive disorder prevention. She promoted the standardized application of simple cognitive screening scales in China, advocating "early screening, early diagnosis, and early intervention" to help numerous cognitive disorder patients and their families receive scientific guidance. She is deeply trusted and respected by patients and their families, and is a pioneer in the field of dementia and cognitive disorders in China.